# Aligned Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aligned-bio

- Industry: Biotechnology
- Headquarters: Lund, Sweden
- Website: www.alignedbio.com
- Total disclosed funding: $3.3M
- Latest round: Series A (Feb 4, 2021)
- Investors on record: 4

## About

Based in Sweden, Aligned Bio specializes in developing advanced nanodevice technologies for single molecule detection, enhancing DNA sequencing and biomarker detection for various applications. Founded in 2019 in Lund, Sweden, Aligned Bio focuses on nanowire technology to improve molecular detection. The company was established by Björn Agnarsson and Heiner Linke and has completed one funding deal. In July 2026, Aligned Bio raised SEK 35 million in venture funding led by new investor LMK Venture, with participation from other new investor I Love Lund and returning investors ALMI Invest, LU Innovation System and STOAF. Other unspecified investors also participated in the round.
Aligned Bio specializes in nanowire single molecule detection technology, offering a flagship nanowire-based DNA sequencer that delivers eight times more data efficiently and cost-effectively. Their customizable platforms enable sensitive detection of low-abundance biomolecules, catering to research institutions, biotechnology companies, and healthcare providers mainly in Europe and North America.

## Funding rounds

- Series A, Feb 4, 2021, $2.7M — ALMI Invest, STOAF, Mist Ventures
- Seed, Nov 13, 2019, $0.5M — ALMI Invest, LU Innovation System, Mist Ventures

## Investors

- ALMI Invest — Seed, Series A
- LU Innovation System — Seed
- Mist Ventures (https://capitalatlas.ai/funds/mist-ventures) — Seed, Series A
- STOAF (https://capitalatlas.ai/funds/stoaf) — Series A